Track the Aurobindo Pharma Limited share price and the full directors' dealings record of the company, a listed equity based in India. Shares trade on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Aurobindo Pharma Limited has logged 168 public disclosures. Market capitalisation: €674bn. The latest transaction was reported on 30 March 2024 (Pledge). Among the most active insiders: RPR SONS ADVISORS PVT.LTD., P.SUNEELA RANI (Jointly holding). All data is accessible without an account.
168
Insider Decl.
0
Thresholds
€1m
4 ops.
Buy Volume
€11m
65 ops.
Sell Volume
10Σ signal
Buys €1m€11m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 8,487 of 25,619 companies
60.1
score / 100
Value
51
Quality
69
FCF yld2.7%
Earn yld3.8%
EV/EBITDA13.6x
ROE9.9%
Gross mgn60%
Net mgn10%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1,350 shares@ ₹1,022.40100.0% of flowEquity SharesSEBI:341d575722aca4b11c47ea3f5cca633fa64cc343
25 of 168 declarations
About Aurobindo Pharma Limited
Aurobindo Pharma Limited is an Indian pharmaceutical company specializing in the manufacture of generic drugs and pharmaceutical products. It is listed on the Bombay Stock Exchange under the symbol XBOM.